Literature DB >> 3124325

Plasminogen activator in bladder tumors.

S Mitsubayashi1, T Akiyama, T Kurita, K Okada, H Bando, T Sakai, O Matsuo.   

Abstract

Plasminogen activator was recovered from bladder tumors by 30% ammonium sulfate precipitation, acid treatment and concanavalin A-Sepharose affinity chromatography to a purification factor of about 80,000. The pooled fraction from the binding protein to concanavalin A-Sepharose revealed a single enzymatically active band with molecular weight of 55,000, which lost its enzymatic activity in the absence of plasminogen. The enzymatic activity was inactivated by DFP. The purified plasminogen activator reacted with antibody against UK, and not with that against t-PA. The purified plasminogen activator cleaved S-228 to a greater extent than S-2444, although UK cleaved S-2444 to a greater extent that S-2288. The enzymatic activity was strongly inhibited by basic pancreatic trypsin inhibitor, and benzamidine. These results suggest that the plasminogen activator in bladder tumors may belong to a different category of plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124325     DOI: 10.1007/bf00265662

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

1.  Urokinase inhibitor in patients with bladder cancer.

Authors:  H Hisazumi; K Naito; T Misaki; S Kosaka
Journal:  Urol Res       Date:  1974-12-20

2.  A study on fibrinolysis in experimental bladder tumors.

Authors:  H Hisazumi; K Fukushima
Journal:  Urol Res       Date:  1973-12

3.  Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.

Authors:  O Matsuo; D C Rijken; D Collen
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

4.  Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.

Authors:  P Friberger
Journal:  Scand J Clin Lab Invest Suppl       Date:  1982

5.  Effect of urokinase on fibrinolysis and fibrinogenolysis.

Authors:  O Matsuo; Y Nishida; K Akazawa; H Mihara
Journal:  Jpn J Physiol       Date:  1982

6.  The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.

Authors:  W A Günzler; G J Steffens; F Otting; S M Kim; E Frankus; L Flohé
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-10

7.  [An immunological study of plasminogen activator activity in the bladder (author's transl)].

Authors:  H Hisazumi; K Naito
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1974-08

8.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

9.  Monoclonal antibody to human tissue plasminogen activator.

Authors:  O Matsuo; Y Tanbara; K Okada; H Bando; T Nagoya
Journal:  Thromb Res       Date:  1984-12-15       Impact factor: 3.944

10.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

Authors:  D C Rijken; D Collen
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

  10 in total
  4 in total

1.  Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.

Authors:  S Shetty; S Idell
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.

Authors:  H Oda; T Oda; H Ohoka; M Yokoyama; M Takeuchi
Journal:  Urol Res       Date:  1990

4.  Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.

Authors:  Praveenkumar Shetty; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Ming C Liu; Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2009-09-26       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.